Systemic Lupus Erythematosus
Cross-source consensus on Systemic Lupus Erythematosus from 1 sources and 4 claims.
1 sources · 4 claims
Benefits
Comparisons
Evidence quality
Highlighted claims
- SLE is the most developed autoimmune indication for CAR T therapy in the article. — Resetting autoimmune disease with CAR cell therapies
- A lupus nephritis patient requiring haemodialysis recovered renal function after CAR T infusion. — Resetting autoimmune disease with CAR cell therapies
- CAR T-mediated depletion in SLE produces transcriptional effects that differ from conventional pharmacotherapy. — Resetting autoimmune disease with CAR cell therapies
- SLE-specific CAR T guidance has been developed by a multi-partner, multi-disciplinary working group. — Resetting autoimmune disease with CAR cell therapies